共 183 条
[1]
Dienstag JL(1998)Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 339 61-8
[2]
Schiff ER(1991)Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′thiacytidine and related analogues Proc Natl Acad Sci USA 88 8495-9
[3]
Wright TL(2000)Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B Gastroenterology 119 172-80
[4]
Perrillo RP(2003)Histological outcome during long-term lamivudine therapy Gastroenterology 124 105-17
[5]
Hann HWL(1999)Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection J Hepatol 30 743-8
[6]
Goodman Z(1996)Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine Hepatology 3 711-3
[7]
Doong SL(1998)Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine therapy J Infect Dis 177 1382-5
[8]
Tsia CH(1996)Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo Hepatology 3 714-7
[9]
Schinazi RF(2000)Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B Hepatology 32 1078-88
[10]
Liotta DC(2002)Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy J Hepatol 37 824-30